The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India

Acta Tropica
B V BabuG Mallick

Abstract

This paper is based on 1 year round case control study to investigate the economic burden, in terms of treatment costs and loss of work to people affected with chronic lymphatic filariasis in rural communities of Orissa, Eastern India. Around three-fourths of the chronic patients have sought treatment for their condition and spent, on average an amount of INR 396 (approximately US$ 8.7) per year. The major component of the expenditure is the cost of medicines. The data on loss of work time due to chronic condition reveal that the total absenteeism to the work is significantly higher among chronic filariasis patients than controls. The total number of working hours spent per day by patients and controls are 4.94 and 6.06, respectively with a significant difference. The total absenteeism and the total number of working hours per day are influenced significantly by disease condition and other personal characteristics, namely age, sex and family type. The chronic patients lose a total of 68 days of work per year, which is equivalent to 19% of the total working time of the year. The present results show that the chronic conditions of lymphatic filariasis pose considerable burden on the patient, family and community.

References

Nov 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·K RamuD Evans
Oct 7, 1997·Tropical Medicine & International Health : TM & IH·K D RamaiahP K Das
Apr 15, 1999·Tropical Medicine & International Health : TM & IH·K D RamaiahP K Das
May 29, 2000·Parasitology Today·K D RamaiahH Guyatt

❮ Previous
Next ❯

Citations

Nov 20, 2004·Emerging Infectious Diseases·Susan F WilsonDavid G Addiss
Mar 19, 2013·BMC Health Services Research·Oforbuike EwelukwaObinna Onwujekwe
Jul 11, 2006·Tropical Medicine & International Health : TM & IH·Fasil TekolaGail Davey
Mar 4, 2009·Tropical Medicine & International Health : TM & IH·Jane GoudgeAnne Mills
Nov 30, 2012·Tropical Medicine & International Health : TM & IH·Ede Tyrell
Jun 9, 2006·Vaccine·Peter J Hotez, Meghan T Ferris
Jun 14, 2003·Annals of Tropical Medicine and Parasitology·B V Babu, A N Nayak
May 1, 2015·BMC Health Services Research·Marta QuintussiFrans Rutten
Apr 16, 2003·Filaria Journal·Jeevan B SherchandMarcel Hommel
Feb 26, 2015·American Journal of Public Health·Theodore C BaileyFabrizio Tediosi
Jul 9, 2016·Infectious Diseases of Poverty·Hugo C TurnerMark H Bradley
Aug 23, 2016·PLoS Neglected Tropical Diseases·Victoria WalshLeAnne M Fox
Nov 18, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·B V BabuA S Kerketta
Aug 31, 2016·The American Journal of Tropical Medicine and Hygiene·Eileen StillwaggonLeAnne Fox
Apr 4, 2017·Infectious Diseases of Poverty·Michelle C StantonLouise A Kelly-Hope
Mar 17, 2006·Transactions of the Royal Society of Tropical Medicine and Hygiene·David Canning
Aug 18, 2004·International Journal of Clinical Practice·H Schuster
May 13, 2017·Neurosurgery·Rachel KleinloogYnte M Ruigrok
Jul 13, 2020·The American Journal of Tropical Medicine and Hygiene·Larry Sawers, Eileen Stillwaggon
Oct 12, 2016·International Journal for Equity in Health·Md Sadik PavelJeff Gow
Mar 27, 2020·PLoS Neglected Tropical Diseases·Larry SawersLouise A Kelly-Hope
Sep 1, 2006·PharmacoEconomics·Ebere AkobunduC Daniel Mullins
Nov 11, 2020·Transactions of the Royal Society of Tropical Medicine and Hygiene·Anna T Van't NoordendeAlice P Schippers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.